Search
/cn/en/product/content-promo-band
http://www.alk-abello.com/investor/agm/Documents/ALK_AR15.pdf, media
/cn/product/content-promo-band
http://www.alk-abello.com/investor/agm/Documents/ALK_AR15.pdf, media
/cn/en/page/owners
Owners, Our owners’ contribution to society, rails_0 (1).jpg
,
A stable ownership structure, The Lundbeck Foundation (Lundbeckfonden) has a 40.3% interest (including A shares) and the Danish pension fund ATP has a 5.1% interest. Of the 30 larg
,
Examples of grants from Lundbeckfonden, 2013, 2014, 2015
,
Overview of the Lundbeck Foundation, ALK’s controlling shareholderThe Lundbeck Foundation is the largest and controlling shareholder of ALK, owning 67% of the votes (40% of the capital).D, Left, Read more about the Lundbeck Foundation
/cn/en/node/57
ALK announces top-line results from the five-year landmark GRAZAX® Asthma Prevention (GAP) trial in children, Left, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announces top-line results from the GRAZAX® Asthma Prevention (GAP) trial with ALK’s aller…
/cn/node/57
ALK announces top-line results from the five-year landmark GRAZAX® Asthma Prevention (GAP) trial in children, Left, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announces top-line results from the GRAZAX® Asthma Prevention (GAP) trial with ALK’s aller…
/cn/en/node/50
Journal of the American Medical Association publishes Phase III data from allergic asthma trial with ALK's house dust mite SLIT-tablet, ACARIZAX®, Left, Professor J. Christian Virchow, University of Rostock, lead author of the publication said: “JAMA…
/cn/node/50
Journal of the American Medical Association publishes Phase III data from allergic asthma trial with ALK's house dust mite SLIT-tablet, ACARIZAX®, Left, Professor J. Christian Virchow, University of Rostock, lead author of the publication said: “JAMA…